NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
OHSU Knight Cancer Institute
St. Jude Children's Research Hospital
Massachusetts General Hospital
Roswell Park Cancer Institute
Duke University
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Novartis